Web1 de dez. de 2015 · Since May 1986, we have treated 98 patients with acute myeloid leukemia (AML) on a protocol consisting of induction with mitoxantrone (10 mg/m2) for 4 days and cytosine arabinoside (Ara-C) (100 mg ... Web1 de jun. de 1997 · Ara-C was administered at a dose of 3 g/m 2 every 12 h by 2-h intravenous infusion on days 1–4 (8 doses) and mitoxantrone at a dose of 6 mg/m 2 /day on days 1–5 (5 doses). Granulocyte colony-stimulating factor (G-CSF) was administered at a dose of 300 µg/day by subcutaneous injection when patients' WBC was <1000/µl for …
High-Dose Cytarabine and Mitoxantrone as Salvage Therapy for …
Web12 de abr. de 2024 · Fludarabine is a commonly used conditioning agent but as 60% of the active metabolite 2-fluoro-ara-A (F-ARA-A) is cleared by the kidney, concerns for fludarabine-induced neurotoxicity are high [6 ... WebCytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic … GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma F. Del Bufal… H.-J. Wang and S.C.-S. Hu N Engl J Med 2024; 388:1031-1031 A 30-year-old wo… Explore a collection of articles and other resources on the Coronavirus (Covid-19… Unfortunately, the prevalence of this common, costly, and painful condition is incr… Image Challenge from the New England Journal of Medicine — April 13, 2024 fish treats for dogs uk
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD …
Web11 de abr. de 2024 · Currently, high doses of cytarabine arabinoside (Ara-C)-based combined chemotherapy are commonly used in acute myeloid leukemia (AML) therapy, … Web18 de nov. de 2011 · High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside ... In pts >45 who reached CR, the decrease in the relapse rate in the HD-Ara-C arm vrs SD … WebR-HDAC, or R-HD-AraC (ituximab plus (H)igh (D)ose ra-) is a chemotherapy regimen that is used, alternating with R-Maxi-CHOP, as part of so-called "Nordic protocol" of treating mantle cell lymphoma.It consists of monoclonal antibody rituximab and high-dose antimetabolite cytarabine.. High-dose Ara-C (HDAC) without rituximab also has several other uses in … candy dulfer and dave koz